US Patent Issued to SRI International on Sept. 22 for "Lipoxygenase inhibitors" (California Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,926, issued on Sept. 22, was assigned to SRI International (Menlo Park, Calif.).

"Lipoxygenase inhibitors" was invented by Ling Jong (Menlo Park, Calif.), Nathan Collins (Menlo Park, Calif.) and Raymond Ng (Menlo Park, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Various embodiments of the present disclosure are directed to compounds having Formula I, Formula II, Formula IIA, Formula III, Formula IIIA, Formula IIIB, and/or pharmaceutically acceptable salts thereof. The compounds can be suitable for inhibiting lipoxygenases and/or treating associated diseases. In some embodiments, subject compounds are used to prepare a composition that is ...